Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.41 USD | -2.43% | -6.37% | +4.08% |
05-09 | Earnings Flash (VYNE) VYNE THERAPEUTICS Posts Q1 Revenue $98,000 | MT |
05-09 | VYNE Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.08% | 35.88M | |
+42.56% | 748B | |
+34.06% | 598B | |
-5.51% | 356B | |
+17.93% | 325B | |
+4.65% | 283B | |
+17.37% | 245B | |
+9.11% | 211B | |
-4.09% | 209B | |
+2.59% | 166B |
- Stock Market
- Equities
- VYNE Stock
- News VYNE Therapeutics Inc.
- Transcript : Menlo Therapeutics Inc., Q1 2020 Earnings Call, May 11, 2020